Alzheimer's and dementia news covering clinical trials, biomarkers, caregiving, policy, and neuroscience of cognitive decline.
A Finnish study identifies depression, vertigo, and headaches as potential early indicators of early-onset Alzheimer's disease. Researchers found these conditions were significantly more common in patients five years before diagnosis, offering clues for earlier detection compared to previous late-onset studies.
A new review published in the Journal of the Endocrine Society suggests a potential link between polycystic ovary syndrome (PMOS) and increased dementia risk in women. Researchers from the U.S. and Iran outline possible metabolic mechanisms but caution that clinical evidence remains inconsistent, urging focus on metabolic health while further study is conducted.
The author, a former leader and writer, argues that Alzheimer's disease threatens their identity but contends that core human essence endures. They share personal experiences to help others understand the condition and support patients facing this progressive loss of self.
The Alzheimer's Association is organizing a fundraising walk in Pittsburgh to support research and family resources. The piece highlights recent medical advancements, including FDA-approved blood tests developed at the University of Pittsburgh, while emphasizing the social isolation associated with the disease and the importance of clinical support helplines.
A University of Pittsburgh-led study published in JAMA Psychiatry reports that adults with ADHD face more than four times the risk of dementia or mild cognitive impairment. Analyzing over 187,000 older adults, researchers found significant associations between the disorder and cognitive decline, though they caution the link is correlational rather than causal.
New research published in JAMA Neurology projects annual dementia cases will rise from 11.4 million in 2023 to 24.7 million by 2050, a decade earlier than previous estimates. Experts label the accelerating trend an epidemic crisis driven by aging demographics and higher incidence rates among women and residents of low- and middle-income countries.